Stanford’s 2nd annual Race for Pulmonary Hypertension is being held on campus Oct. 27 at 9 a.m. Proceeds from the 5K run or walk will go to the Pulmonary Hypertension Association and a fund that supports patient care and research at Stanford’s Vera Moulton Wall Center for Pulmonary Vascular Disease.
More than 250 people attended the event last year. "It’s important to raise awareness and funding for this disorder," said Virginia Coglitore, an area resident who was treated for the disorder last year at Stanford Hospital and is participating in the event this year.
"Pulmonary hypertension doesn’t sound like a big deal — it sounds like you have high blood pressure — but it’s more serious than you would think."
Pulmonary arterial hypertension, an incurable disease in which the blood pressure in the pulmonary artery rises too high, leads to fatigue, shortness of breath, chest pain and fainting. It is often misdiagnosed (Coglitore’s symptoms were attributed to her pregnancy and, later, to asthma) and can have a poor survival rate. A number of new treatments have had success in treating symptoms and slowing the progression of the disease.
Stanford’s event is sponsored by the Wall Center and the companies Actelion, Accredo Therapeutics, INO Therapeutics, JIBE Marketing and eAgency.
For more information or to register, please call (800) 640-WALL, or visit the race’s Web site at http://www.raceforph.org.
Stanford Report, October 16, 2002